News

When the stars align

Doctor, academic, classics student, arts patron and philanthropist Paul Eliadis believes in not only saving lives but culturally enriching them

Ponatinib Facilitates Treatment-free Remission by P075 Inducing Deep Molecular Responses

Multiple trials now demonstrate the potential for success and the safety of an attempt at treatment-free remission (TFR) in patients with sustained deep molecular response to tyrosine kinase inhibitors (TKIs) [1,2,3].

The current clinical trials that Dr Eliadis is a Principle Investigator

Acute life-threatening reversible pulmonary vasoconstrictive reaction to bleomycin chemotherapy demonstrating the clinical application of ePLAR – echocardiographic Pulmonary to Left Atrial Ratio

22 February 2016 Journal of Clinical Oncology

SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer